KathrynTrinhFongMD

PubMed

• Evaluation of ocrelizumab in older progressive multiple sclerosis patients.
  Samantha Epstein, K. Fong, Philip L. De Jager, Libby Levine, Claire S Riley, Sarah Wesley, Wendy Vargas, Rebecca Farber> ;Multiple sclerosis and related disorders. 2021 Jul 25
• Fatal COVID-19 in an MS patient on natalizumab: A case report.
  Rimmer K, Farber R, Thakur K, Braverman G, Podolsky D, Sutherland L, Migliore C, Ryu YK, Levin S, De Jager PL, Vargas W, Levine L, Riley CS> ;Multiple sclerosis journal - experimental, translational and clinical. 2020-08-10
• Neuroimmunologic disorders in pregnancy.
  Levin S, Rimmer K, Vargas WS> ;Handbook of clinical neurology.
• 24 citations
  Potential Neurologic Manifestations of COVID-19
  Anna S. Nordvig, K. Fong, Joshua Z. Willey, Kiran T. Thakur, Amelia K. Boehme, Wendy Vargas, Craig J. Smith, Mitchell S.V. Elkind> ;Neurology. Clinical practice. 2021 Apr 1
• Central nervous system disease with JC virus infection in adults with congenital HIV.
  Caleb R.S. McEntire, Kathryn T Fong, Dan Tong Jia, Ellen R. Cooper, Anna M. Cervantes-Arslanian, Farrah J. Mateen, Pria Anand, Kiran T. Thakur> ;AIDS. 2021 Feb 2
• 2 citations
  Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consorti...
  Sylvia Klineova, Asaff Harel, Rebecca Straus Farber, Tracy DeAngelis, Yinan Zhang, Roland Hentz, Tung Ming Leung, K. Fong, Tyler Smith, Richard Blanck, Lana Zhovtis-Ry...> ;Multiple sclerosis and related disorders. 2021 Jul 19
• Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases.
  Levin SN, Venkatesh S, Nelson KE, Li Y, Aguerre I, Zhu W, Masown K, Rimmer KT, Diaconu CI, Onomichi KB, Leavitt VM, Levine LL, Strauss-Farber R, Vargas WS, Banwell B, ...> ;Annals of clinical and translational neurology. 2021-02-22
• Prevalence and Characteristics of Neuroinfectious Disease Inquiries Within the Emerging Infections Network: A 22-Year Retrospective Study.
  Matthews E, Diaz-Arias LA, Beekmann SE, Polgreen P, Waldrop G, Yang V, Rimmer K, Venkatesan A, Thakur KT> ;Open forum infectious diseases. 2020-05-09
• Zika Virus and Neurologic Disease.
  Reid S, Rimmer K, Thakur K> ;Neurologic clinics.
• International Issues: A guide to US academic global health programs in neurology.
  Samudralwar RD, Goss A, Rimmer K, Shetler K, Navis A, Siddiqi OK, Chin JH, Thakur KT> ;Neurology.
• Expanding medicines for neurologic disorders on the WHO Model List.
  Rimmer K, Shah H, Thakur K> ;Neurology.
• Join now to see all

Journal Articles

• Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consorti...  
  Klineova S, Harel A, Straus Farber R, DeAngelis T, Zhang Y, Hentz R, Ming Leung T, Fong KT, Smith T, Blanck R, Zhovtis-Ryerson L, Multiple Sclerosis and Related Disorders, 10/1/2021

Books/Book Chapters

• Neurology and Pregnancy, Vol 172 
  Chapter: Neuroimmunological Disorders in Pregnancy 
  Seth Levin; Kathryn T. Rimmer; Wendy VargasEditors: Eric A.P. Steegers; Marilyn J. Cipolla; Eliza C. Miller.ElsevierEdition 1st,2020

Abstracts/Posters

• Epidemiology of COVID-19 among persons with neuroimmunological disorders at the Columbia University MS Center in New York City
  Fong KT, Epstein SE, Thakur KT, Boehme AK, De Jager PL, Vargas WS, Levine L, Riley CS, Straus Farber R, MSVirtual2020, 9/25/2020
• COVID-19 Infection in Patients with Multiple Sclerosis: an observational study by The New York COVID-19 Neuro-Immunology Consortium (NYCNIC)
  Klineova S, Harel A, Farber R, Zhang Y, DeAngelis T, Leung TM, Fong K, Smith T, Blanck R, Filomena S, Karran M, Gurgova S, Onomichi K, Zhovtis-Ryerson L, MSVirtual2020, 9/25/2020
• Progressive MS patients of older age on ocrelizumab: real-world experience at Columbia University Irving Medical Center
  Epstein SE, Fong KT, De Jager PL, Riley CS, Levine L, Vargas WS, Straus Farber R, MS Virtual 2020, 9/11/2020
• Severe multiple sclerosis relapse with tumefactive lesion while transitioning between fingolimod and rituximab
  Rimmer K, Riley CS, De Jager PL, European Committee for Treatment and Research in Multiple Sclerosis, Sotckholm, Sweden, 9/11/2019
• Join now to see all